• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗原非依赖性、自主的 B 细胞受体信号驱动激活的 B 细胞弥漫性大 B 细胞淋巴瘤。

Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.

机构信息

Department of Hematology, Leiden University Medical Center, Leiden, Netherlands.

BIOCEV, First Faculty of Medicine, Charles University , Prague, Czech Republic.

出版信息

J Exp Med. 2024 May 6;221(5). doi: 10.1084/jem.20230941. Epub 2024 Mar 21.

DOI:10.1084/jem.20230941
PMID:38512136
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10959178/
Abstract

Diffuse large B cell lymphoma of activated B cell type (ABC-DLBCL), a major cell-of-origin DLBCL subtype, is characterized by chronic active B cell receptor (BCR) signaling and NF-κB activation, which can be explained by activating mutations of the BCR signaling cascade in a minority of cases. We demonstrate that autonomous BCR signaling, akin to its essential pathogenetic role in chronic lymphocytic leukemia (CLL), can explain chronic active BCR signaling in ABC-DLBCL. 13 of 18 tested DLBCL-derived BCR, including 12 cases selected for expression of IgM, induced spontaneous calcium flux and increased phosphorylation of the BCR signaling cascade in murine triple knockout pre-B cells without antigenic stimulation or external BCR crosslinking. Autonomous BCR signaling was associated with IgM isotype, dependent on somatic BCR mutations and individual HCDR3 sequences, and largely restricted to non-GCB DLBCL. Autonomous BCR signaling represents a novel immunological oncogenic driver mechanism in DLBCL originating from individual BCR sequences and adds a new dimension to currently proposed genetics- and transcriptomics-based DLBCL classifications.

摘要

活化 B 细胞型弥漫性大 B 细胞淋巴瘤(ABC-DLBCL)是主要的生发中心来源的 DLBCL 亚型,其特征为慢性激活的 B 细胞受体(BCR)信号和 NF-κB 激活,少数病例存在 BCR 信号级联的激活突变,可对此加以解释。我们证明,类似于其在慢性淋巴细胞白血病(CLL)中的重要发病机制作用,自主 BCR 信号可以解释 ABC-DLBCL 中的慢性激活的 BCR 信号。在未经抗原刺激或外部 BCR 交联的情况下,我们测试的 18 种源自 DLBCL 的 BCR 中的 13 种,包括为 IgM 表达而选择的 12 种案例,可诱导小鼠三基因敲除前 B 细胞中自发的钙离子流和 BCR 信号级联的磷酸化。自主 BCR 信号与 IgM 同型相关,依赖于体细胞 BCR 突变和个体 HCDR3 序列,且主要局限于非生发中心 B 细胞来源的 DLBCL。自主 BCR 信号代表源自个体 BCR 序列的 DLBCL 中的一种新的免疫致癌驱动机制,为目前提出的基于遗传学和转录组学的 DLBCL 分类增加了一个新的维度。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/1dc1993ffb23/JEM_20230941_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/0e3a49271ef1/JEM_20230941_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/aadbbf46d3b8/JEM_20230941_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/ea5f1b71b320/JEM_20230941_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/73fe32201696/JEM_20230941_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/395e62e1cc34/JEM_20230941_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/e03307cea1a3/JEM_20230941_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/1dc1993ffb23/JEM_20230941_FigS2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/0e3a49271ef1/JEM_20230941_Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/aadbbf46d3b8/JEM_20230941_FigS1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/ea5f1b71b320/JEM_20230941_Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/73fe32201696/JEM_20230941_Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/395e62e1cc34/JEM_20230941_Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/e03307cea1a3/JEM_20230941_Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0993/10959178/1dc1993ffb23/JEM_20230941_FigS2.jpg

相似文献

1
Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.抗原非依赖性、自主的 B 细胞受体信号驱动激活的 B 细胞弥漫性大 B 细胞淋巴瘤。
J Exp Med. 2024 May 6;221(5). doi: 10.1084/jem.20230941. Epub 2024 Mar 21.
2
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma.弥漫性大 B 细胞淋巴瘤中慢性活性 B 细胞受体信号转导。
Nature. 2010 Jan 7;463(7277):88-92. doi: 10.1038/nature08638.
3
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma.在弥漫性大B细胞淋巴瘤中使用依鲁替尼靶向B细胞受体信号传导
Nat Med. 2015 Aug;21(8):922-6. doi: 10.1038/nm.3884. Epub 2015 Jul 20.
4
The isotype of the BCR as a surrogate for the GCB and ABC molecular subtypes in diffuse large B-cell lymphoma.BCR 同种型可作为弥漫性大 B 细胞淋巴瘤中 GCB 和 ABC 分子亚型的替代物。
Leukemia. 2011 Apr;25(4):681-8. doi: 10.1038/leu.2010.302. Epub 2011 Jan 14.
5
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中的强直性B细胞受体信号传导
Blood. 2017 Aug 24;130(8):995-1006. doi: 10.1182/blood-2016-10-747303. Epub 2017 Jun 23.
6
ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma.ASB2 是 FLI1 的直接靶标,可维持生发中心衍生弥漫性大 B 细胞淋巴瘤中 NF-κB 通路的激活。
J Exp Clin Cancer Res. 2021 Nov 11;40(1):357. doi: 10.1186/s13046-021-02159-3.
7
Diffuse large B-cell lymphoma in Southeast Asian cohort: expression patterns of B-cell receptor (BCR) repertoire and its linkage with molecular subtypes and response to R-CHOP therapy.东南亚队列中的弥漫性大 B 细胞淋巴瘤:B 细胞受体(BCR)库的表达模式及其与分子亚型的关联以及对 R-CHOP 治疗的反应。
J Clin Pathol. 2019 Sep;72(9):630-635. doi: 10.1136/jclinpath-2019-205837. Epub 2019 Jun 12.
8
Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.通过B细胞受体的持续信号传导诱导Mcl-1并促进慢性淋巴细胞白血病B细胞的存活。
Blood. 2005 Jun 15;105(12):4820-7. doi: 10.1182/blood-2004-07-2669. Epub 2005 Feb 22.
9
B-cell receptor signaling in diffuse large B-cell lymphoma.弥漫性大B细胞淋巴瘤中的B细胞受体信号传导
Semin Hematol. 2015 Apr;52(2):77-85. doi: 10.1053/j.seminhematol.2015.01.008. Epub 2015 Jan 15.
10
Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.致淋巴瘤的CARD11/BCL10/MALT1信号通路通过协同激活NF-κB和JNK驱动恶性B细胞增殖。
Proc Natl Acad Sci U S A. 2015 Dec 29;112(52):E7230-8. doi: 10.1073/pnas.1507459112. Epub 2015 Dec 14.

引用本文的文献

1
Multi-Cohort High-Dimensional Proteomics Reveals Early Risk Markers for Lymphoid Cancer Subtypes.多队列高维蛋白质组学揭示淋巴癌亚型的早期风险标志物。
Res Sq. 2025 Aug 19:rs.3.rs-7400676. doi: 10.21203/rs.3.rs-7400676/v1.
2
CXCR4 Inhibition Enhances the Efficacy of CD19 Monoclonal Antibody-Mediated Extermination of B-Cell Lymphoma.CXCR4抑制增强CD19单克隆抗体介导的B细胞淋巴瘤清除效果。
Int J Mol Sci. 2025 Feb 26;26(5):2024. doi: 10.3390/ijms26052024.
3
Tumor Biology Hides Novel Therapeutic Approaches to Diffuse Large B-Cell Lymphoma: A Narrative Review.

本文引用的文献

1
Autonomous B-cell receptor signaling and genetic aberrations in chronic lymphocytic leukemia-phenotype monoclonal B lymphocytosis in siblings of patients with chronic lymphocytic leukemia.慢性淋巴细胞白血病患者的兄弟姐妹中存在单克隆 B 淋巴细胞增多症-表型,其具有自主 B 细胞受体信号和遗传异常。
Haematologica. 2024 Mar 1;109(3):824-834. doi: 10.3324/haematol.2022.282542.
2
KEGG for taxonomy-based analysis of pathways and genomes.KEGG 用于基于分类的途径和基因组分析。
Nucleic Acids Res. 2023 Jan 6;51(D1):D587-D592. doi: 10.1093/nar/gkac963.
3
A bioinformatics perspective on molecular classification of diffuse large B-cell lymphoma.
肿瘤生物学隐藏了弥漫性大 B 细胞淋巴瘤的新治疗方法:叙述性综述。
Int J Mol Sci. 2024 Oct 23;25(21):11384. doi: 10.3390/ijms252111384.
4
The role of lncRNA binding to RNA‑binding proteins to regulate mRNA stability in cancer progression and drug resistance mechanisms (Review).长链非编码 RNA 与 RNA 结合蛋白在调控肿瘤进展和耐药机制中 mRNA 稳定性的作用(综述)。
Oncol Rep. 2024 Nov;52(5). doi: 10.3892/or.2024.8801. Epub 2024 Sep 2.
5
Molecular Subtypes and the Role of TP53 in Diffuse Large B-Cell Lymphoma and Richter Syndrome.分子亚型及TP53在弥漫性大B细胞淋巴瘤和里氏综合征中的作用
Cancers (Basel). 2024 Jun 7;16(12):2170. doi: 10.3390/cancers16122170.
弥漫性大B细胞淋巴瘤分子分类的生物信息学视角
Leukemia. 2022 Sep;36(9):2177-2179. doi: 10.1038/s41375-022-01670-6. Epub 2022 Aug 6.
4
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms.《世界卫生组织造血与淋巴组织肿瘤分类》第五版:淋巴肿瘤。
Leukemia. 2022 Jul;36(7):1720-1748. doi: 10.1038/s41375-022-01620-2. Epub 2022 Jun 22.
5
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee.成熟淋巴细胞肿瘤国际共识分类:临床咨询委员会报告。
Blood. 2022 Sep 15;140(11):1229-1253. doi: 10.1182/blood.2022015851.
6
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL.伊布替尼联合 R-CHOP 化疗治疗弥漫性大 B 细胞淋巴瘤的遗传学亚型。
Cancer Cell. 2021 Dec 13;39(12):1643-1653.e3. doi: 10.1016/j.ccell.2021.10.006. Epub 2021 Nov 4.
7
Robust detection of translocations in lymphoma FFPE samples using targeted locus capture-based sequencing.使用靶向基因捕获测序技术在淋巴瘤 FFPE 样本中进行稳健的易位检测。
Nat Commun. 2021 Jun 7;12(1):3361. doi: 10.1038/s41467-021-23695-8.
8
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphoma.鉴定非典型修饰的自身抗原Ars2为活化B细胞型弥漫性大B细胞淋巴瘤中B细胞受体的靶点。
Haematologica. 2021 Aug 1;106(8):2224-2232. doi: 10.3324/haematol.2019.241653.
9
A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.具有治疗意义的弥漫性大 B 细胞淋巴瘤遗传亚型的概率分类工具。
Cancer Cell. 2020 Apr 13;37(4):551-568.e14. doi: 10.1016/j.ccell.2020.03.015.
10
Sarek: A portable workflow for whole-genome sequencing analysis of germline and somatic variants.萨雷克:用于种系和体细胞变异的全基因组测序分析的便携式工作流程。
F1000Res. 2020 Jan 29;9:63. doi: 10.12688/f1000research.16665.2. eCollection 2020.